Recce Pharmaceuticals Ltd (ASX:RCE) Directors Insider Transactions



The Directors and Chief Executives of Recce Pharmaceuticals Ltd (ASX:RCE) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Recce Pharmaceuticals Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Recce Pharmaceuticals Ltd to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Recce Pharmaceuticals Ltd Directors/Insider Transactions Activity

List of Insider trades activity from Recce Pharmaceuticals Ltd (RCE).

Date Director Director's Title Shares Value Note
30 Jun 2025 Kollaras (Arthur) Divisional Officer 15,359 - -
16 May 2025 Dilizia (Michele Keryn) Director (Executive) 17,857 3,199 Other at price 0.18 per share.
16 May 2025 Dunton (Alan W) Independent Non-Executive Director 19,469 3,488 Other at price 0.18 per share.
16 May 2025 Graham (James Hamilton Bray) Chief Executive Officer 35,714 6,399 Other at price 0.18 per share.
16 May 2025 McKeough (Alistair) Director (Non-Executive) 4,326 775 Other at price 0.18 per share.
16 May 2025 Prendergast (John) Non Executive Chairman 51,136 9,163 Other at price 0.18 per share.
16 May 2025 Ward (Justin) Director (Executive) 50,240 9,003 Other at price 0.18 per share.
30 Jun 2024 Kollaras (Arthur) Divisional Officer 25,000 - -
30 Jun 2024 McKeough (Alistair) Director (Non-Executive) 961 - -